HEP B SURFACE ANTIBODY IMMUNITY, QUANTITATIVE (TITER)

HEP B SURFACE AB QN (HBV Titer); Hepatitis B Surface Antibody Immunity, Quantitative; HBsAb QN; HBsAb Quantitative; Hepatitis B Surface Antibody, Quantitative

Hepatitis B surface antibody (anti-HBs) level can be measured to determine if vaccination is needed. Following a vaccination regimen, anti-HBs can be measured to determine if protective immunity has been achieved.

Hepatitis B is a viral illness that is transmitted through blood and other body fluids. Both acute and chronic stages occur, with the frequency of progression to chronically declining with age at time of infection. 

Chronic hepatitis B often leads to cirrhosis and hepatocellular carcinoma. Hepatitis B is a vaccine preventable disease. 

Hepatitis B surface immunizer quantitation test will decide past openness to the Hepatitis B Virus (HBV) just as invulnerability status of the hepatitis B immunization. Hepatitis B is a genuine liver disease brought about by the Hepatitis B Virus. 

HBV is a serious liver infection and can prompt liver disappointment, cirrhosis (scarring) or malignant growth of the liver. Notwithstanding, HBV is effectively preventable by an immunization.